Readers curious about the science behind persistent post-COVID illness will find a research-focused article exploring immunological hypotheses and promising therapy directions.
Key Takeaways
- Detectable circulating autoantibodies can serve as a biomarker to select patients for immunotherapies.
- Validated autoimmune physiology enables precision trials repurposing IVIG.